the effect of acarbose , an alpha-glucosidase inhibitor , on glycaemic control , was compared with placebo in a double-blind , randomised , group comparison study during 16 weeks in 20 non-obese non-insulin dependent diabetic patients in whom sulphonylurea treatment had been withdrawn .
C0050393
acarbose
C0011860
non